Pirfenidone	NNP	Pirfenidone NNP PennPOS
for	IN	for c-acp NUPOS
the	DT	the dt NUPOS
treatment	NN	treatment NN PennPOS
of	IN	of pp-f NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
an	DT	a dt NUPOS
under-recognised	JJ	under-recognised JJ PennPOS
,	,	, , NUPOS
rare	JJ	rare JJ PennPOS
,	,	, , NUPOS
progressive	JJ	progressive JJ PennPOS
disease	NN	disease NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
lungs	NNS	lung NNS PennPOS
with	IN	with pp NUPOS
unknown	JJ	unknown JJ PennPOS
aetiology	NN	aetiology NN PennPOS
and	CC	and cc NUPOS
high	JJ	high JJ PennPOS
mortality	NN	mortality NN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
currently	RB	current av-j NUPOS
advocated	VBN	advocate VBN PennPOS
pathogenic	JJ	pathogenic JJ PennPOS
mechanism	NN	mechanism NN PennPOS
is	VBZ	be vbz NUPOS
represented	VBN	represent VBN PennPOS
by	IN	by IN PennPOS
progressive	JJ	progressive JJ PennPOS
multifocal	JJ	multifocal JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

It	PRP	it pn31 NUPOS
is	VBZ	be vbz NUPOS
diagnosed	VBN	diagnose VBN PennPOS
based	VBN	base vvn NUPOS
on	IN	on IN PennPOS
clinical	JJ	clinical JJ PennPOS
,	,	, , NUPOS
radiographic	JJ	radiographic JJ PennPOS
,	,	, , NUPOS
physiological	JJ	physiological JJ PennPOS
and	CC	and cc NUPOS
histopathological	JJ	histopathological JJ PennPOS
criteria	NNS	criterion NNS PennPOS
.	.	. . NUPOS

Existing	VBG	exist VBG PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
guidelines	NNS	guideline NNS PennPOS
recommend	VBP	recommend VBP PennPOS
anti-inflammatory	JJ	anti-inflammatory JJ PennPOS
and	CC	and cc NUPOS
immunosuppressive	JJ	immunosuppressive JJ PennPOS
combinations	NNS	combination NNS PennPOS
,	,	, , NUPOS
despite	IN	despite pp NUPOS
proven	JJ	proven JJ PennPOS
limited	JJ	limited JJ PennPOS
efficacy	NN	efficacy NN PennPOS
.	.	. . NUPOS

There	EX	there pc-acp NUPOS
is	VBZ	be vbz NUPOS
no	DT	no dx NUPOS
therapy	NN	therapy NN PennPOS
approved	VBD	approve vvd NUPOS
specifically	RB	specific av-j NUPOS
for	IN	for c-acp NUPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
but	CC	but cc-acp NUPOS
several	JJ	several JJ PennPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
agents	NNS	agent NNS PennPOS
are	VBP	be vbb NUPOS
currently	RB	current av-j NUPOS
under	IN	under IN PennPOS
development	NN	development NN PennPOS
for	IN	for c-acp NUPOS
this	DT	this d NUPOS
indication	NN	indication NN PennPOS
.	.	. . NUPOS

Pirfenidone	NNP	Pirfenidone NNP PennPOS
is	VBZ	be vbz NUPOS
an	DT	a dt NUPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
agent	NN	agent NN PennPOS
potentially	RB	potential av-j NUPOS
effective	JJ	effective JJ PennPOS
for	IN	for c-acp NUPOS
IPF	NN	IPF NN PennPOS
therapy	NN	therapy NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
preclinical	JJ	preclinical JJ PennPOS
and	CC	and cc NUPOS
available	JJ	available JJ PennPOS
clinical	JJ	clinical JJ PennPOS
data	NNS	datum NNS PennPOS
support	VBP	support VBP PennPOS
its	PRP$	its po31 NUPOS
use	NN	use NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

Future	JJ	future JJ PennPOS
clinical	JJ	clinical JJ PennPOS
studies	NNS	study NNS PennPOS
are	VBP	be vbb NUPOS
expected	VBN	expect VBN PennPOS
to	TO	to p-acp NUPOS
provide	VB	provide VBP PennPOS
more	JJR	many JJR PennPOS
consistent	JJ	consistent JJ PennPOS
information	NN	information NN PennPOS
on	IN	on IN PennPOS
survival	NN	survival NN PennPOS
benefit	NN	benefit NN PennPOS
,	,	, , NUPOS
lung	NN	lung NN PennPOS
function	NN	function NN PennPOS
and	CC	and cc NUPOS
health-related	JJ	health-related JJ PennPOS
quality	NN	quality NN PennPOS
of	IN	of pp-f NUPOS
life	NN	life NN PennPOS
.	.	. . NUPOS

